Figure 6 | Scientific Reports

Figure 6

From: Identification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer

Figure 6

Prognostic value of risk signature. (A) BC patients in GSE31684 cohort divided into low-risk and high-risk subgroups according to the median risk score. (B) The survival status of each patient with different risk in GSE31684 cohort. (C) Kaplan–Meier curves of OS in different risk groups of GSE31684 cohort. (D–F) ROC curves of 1-year, 3-year, and 5-year survival rate for the risk signature in train, test and GSE31684 cohort. (G) ROC curves of risk score and clinicopathologic features on the 3-year. (H) Univariate Cox regression for risk score and the clinicopathological features. (I) Multivariate Cox regression for risk score and the clinicopathological features. (J) Nomogram for predicting 1-year, 3-year and 5-year survival rates of BC patients. (K) The calibration curves validate the consistency between the actual outcome and the predicted result for 1-year, 3-year and 5-year survival rates.

Back to article page